TT  Wisconsin Alumni Research Foundation

http://www.warf.org





     Office Locations:

614 Walnut Street, 13th Floor
Madison, WI 53726
Phone: 608-263-2500
Fax: 608-263-1064

 

Stages:

  • Seed


 

Industries:

  • Energy & Clean Tech
  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    WARF is the Wisconsin Alumni Research Foundation, an independent, nonprofit foundation chartered to support research at the UW-Madison and the designated technology transfer organization for the university. WARF is a separate entity from the university but partners closely with it. WARF distributes the income from commercial licenses to the UW-Madison, the inventors and their departments. Each year, WARF contributes over $45 million to fund additional UW-Madison research. WARF maintains an investment fund it may use to invest in its start-up companies that meet certain criteria, including the requirement of a suitable co-investor. WARF currently is working with more than 50 active start-ups whose business markets include therapeutics, research tools, biotechnology, medical devices, food and agriculture, engineering, computer, stem cell and clean technologies. WARF currently holds equity in more than 35 of these companies.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alain Hung Associate Director of Investments
    Carl E. Gulbrandsen Managing Director
    Carrie J. Thome Director of Investments
    Craig Heim Assistant Portfolio Manager
    Luann E. Soule Investment Specialist

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/01/2018


      HealthMyne


      WI


      $15,000,000


      Series B


     

    Portfolio companies include:


      FluGen
        web link


      HealthMyne
        web link


      NeuWave Medical
        web link


      SNUPI Technologies
        web link


     

    Recent News: